Community/Retail

Apretude is an antiretroviral drug that inhibits HIV replication by binding to the active site of integrase and blocking the strand transfer step of retroviral DNA integration.

Daprodustat (Jesduvroq, GSK) is the first oral hypoxia-inducible factor prolyl hydroxylase inhibitor to gain approval in the United States.

Kathy Pham, PharmD, BCPPS, senior director of Policy and Professional Affairs at the American College of Clinical Pharmacy (ACCP), discusses her experience at ACCP and why advocacy is important to health care and the profession of pharmacy.

This is the largest known study to consider medical and recreational cannabis policies with US psychosis-related health care claims.

Rapid antigen tests, which can identify infected individuals before they present symptoms, are considered a promising means of reducing the spread of COVID-19.

COVID-19 vaccines are known to have one of the most complex schedules that the average pharmacist has ever had to manage for a vaccine directed towards a single preventable disease.

The need for pharmacists to return to a more clinically-focused role became apparent as the COVID-19 pandemic revealed gaps in patient access to care across the country.

Amjevita is approved for all indications of reference Humira except for hidradenitis suppurativa.

Providers must carefully prescribe, monitor, and adjust renally relevant drug lists in patients with chronic kidney disease to prevent progression.

Patients with acute migraines should assess their condition before starting a treatment regimen.

Pharmacists play an important role in providing education and support with adherence to PrEP in populations with a high risk for HIV infection.

Intensive health behavior and lifestyle treatment is the most effective behavioral treatment for childhood obesity.

The agency also denied 3 citizen petitions asking for CBD products to be marketed as dietary supplements.

There's no better time to remind pharmacists that they are vital in the fight against CVD.

Social media can leverage pharmacists as personalities and help influence which topics the public discusses and the data they consume, presenter says.

The updated label now includes patients with cold agglutinin disease with or without a history of transfusions.

A community-based multidisciplinary team can have a significant impact addressing health disparities and diabetes management.

Economic food insecurity, associated with cardiovascular mortality, disproportionately impacts Black communities.

Anthony Pudlo, PharmD, MBA, executive director of the Tennessee Pharmacists Association, discussed his presentation at the National Association of Chain Drug Stores (NACDS) 2023 Regional Chain conference.

Pharmacists want you to be on time.

The efficacy and adverse effects associated with COVID-19 vaccines is a leading cause of hesitancy in parents, according to a new study.

The FDA approved a new azole antifungal for recurrent vulvovaginal candidiasis.

The test, called VirSNiP SARS-CoV-2 Spike F486P, is for research use only and specifically targets the unique mutation F486P found within the XBB.1.5 Omicron sub-variant.

Pudlo’s presentation focused on key shifts in chain pharmacies, including pharmacy benefit manager (PBM) reform, pharmacist-administered vaccine trends, and provider status.

The moves come after other efforts to improve staff shortages, including higher wages, lunch breaks, and signing bonuses.

Comprehensive medication management is 1 way to optimize therapy, according to Steven Chen, PharmD, FASHP, FCSHP, FNAP, who spoke at the NACDS Regional 2023 Meeting.

National Association of Chain Drug Stores CEO and president, and 2 other experts discuss the importance of advocacy on the statewide policy level.

With the growing importance of pharmacy services, Chen said pharmacists should think outside the box and get creative when finding effective payment models.

Case studies address questions about a patient with type 2 diabetes and a patient who is curious about nicotine replacement therapy.

Promising results for lecanemab's efficacy in patients with mild cognitive impairment or mild dementia associated with Alzheimer disease were accompanied by reports of adverse effects associated with treatment.